Eagle Pharmaceuticals, Inc. (EGRX) earnings
Quarterly and annual EGRX reports and results, each read against the price at its own news timestamp. Back to the EGRX overview →
11 measured EGRX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements | Press release | — | — | |
| Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements | Press release | — | — | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +0.00% | -16.67% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | +0.00% | -1.22% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | +0.00% | -0.88% | |
| Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K | Press release | -1.71% | +18.18% | |
| Form NT 10-K EAGLE PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | +1.09% | -5.55% | |
| Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q | Press release | -14.74% | -18.27% | |
| Eagle Delays Third Quarter 2023 Results and Conference Call | Press release | -2.96% | -27.67% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +2.26% | -0.11% | |
| Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023 | Press release | -2.06% | -2.63% |
Keep exploring
More EGRX: analyst actions → · SEC filings → · EGRX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | 558 | -0.32% | 41% |
| PERNIX THERAPEUTICS HOLDINGS (PTX) | 557 | -0.19% | 41% |
| Titan Medical Inc. - Ordinary Shares (TMDI) | 552 | -0.06% | 43% |
| Exelixis, Inc. (EXEL) | 548 | -0.02% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.